World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02673502
Date of registration: 28/01/2016
Prospective Registration: Yes
Primary sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Public title: Pre-operative Carbohydrate Drink to Preserve Peri-operative Insulin Sensitivity
Scientific title: Impact of Pre-operative Carbohydrate Drink Provision on Attenuating Peri-operative Insulin Resistant in Major Abdominal Surgery: a Pilot Study
Date of first enrolment: May 2016
Target sample size: 30
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02673502
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Canada
Contacts
Name:     Liane Feldman, MD
Address: 
Telephone:
Email:
Affiliation:  McGill University Health Centre/Research Institute of the McGill University Health Centre
Name:     Francesco Carli, MD
Address: 
Telephone:
Email:
Affiliation:  McGill University Health Centre/Research Institute of the McGill University Health Centre
Key inclusion & exclusion criteria

Inclusion Criteria:

1. At least 18 years of age

2. Planned laparoscopic partial colon resection for non-metastatic neoplastic or benign
disease (including right, transverse, left or sigmoid))

3. HbA1c less than or equal to 5.7%

4. Not receiving any kind of glucose lowering medication.

Exclusion Criteria:

1. Are already diagnosed with diabetes or pre diabetes (HbA1c > 5.7%)

2. Are pre-diabetic receiving glucose lowering intervention (any glucose lowering
medication)

3. Have renal or liver dysfunction (serum creatinine above 1.4 mg/dL in women and 1.5
mg/dL in men, bilirubin >2.9 mg/dL)

4. Will undergo extended resection of adjacent organs

5. Non-elective operations

6. New stoma created

7. Have conditions precluding participation in the ERAS pathway (e.g. dementia, disabling
orthopedic and neuromuscular disease, psychosis)

8. Have conditions requiring preoperative fasting: documented gastroparesis, patient on
metoclopramide and/or domperidone, achalasia, dysphagia (any difficulty with
swallowing), or Fluid restriction (e.g. dialysis, pulmonary oedema, congestive heart
failure).

9. Have cardiac abnormalities, severe end-organ disease such as cardiac failure (New York
Heart Association classes III-IV), chronic obstructive pulmonary disease (documented
by abnormal pulmonary function test), morbid obesity (BMI >40 kg/m2), anemia
(hematocrit < 30 %, hemoglobin <100g/L, albumin < 25mg/dl)

10. Have received steroids for longer than 30 days

11. Have poor English or French comprehension.



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Laparoscopic Abdominal Surgery
Intervention(s)
Dietary Supplement: complex carbohydrate drink
Dietary Supplement: simple carbohydrate drink
Primary Outcome(s)
difference in insulin resistance [Time Frame: Intra-operative from beginning of surgical procedure until the end of the procedure]
Secondary Outcome(s)
Comparing the preoperative hunger [Time Frame: Two times at 2 weeks before surgery (baseline) and immediately before surgery]
Comparing the preoperative thirst [Time Frame: Two times at 2 weeks before surgery (baseline) and immediately before surgery]
Time to readiness for discharge (TRD) [Time Frame: up to 30 days after surgery]
Grip strength [Time Frame: Two times at 2 weeks before surgery (baseline) and 2 days after surgery]
Postoperative infectious complications [Time Frame: 30 days after operation]
Comparing the Homeostasis model assessment (HOMA) index at four different time points ( by employing Fasting blood sugar and Plasma Insulin) [Time Frame: at 4 time points as follow : on the morning before surgery, first, second and third morning after the surgery]
Comparing the preoperative anxiety [Time Frame: Two times at 2 weeks before surgery (baseline) and immediately before surgery]
Comparing the preoperative well-being [Time Frame: Two times at 2 weeks before surgery (baseline) and immediately before surgery]
Secondary ID(s)
15-162-MUHC
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Medtronic - MITG
Mitacs
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history